Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Replimune Group, Inc. (REPL)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Replimune Group, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Replimune Group, Inc. since 2005.
The reporting company's ticker symbol is REPL. The reporting company's CIK number is 1737953.
The total value of stock buying since 2005 is $33,565,200.
The total value of stock sales since 2005 is $5,106,099.
The total value of stock option exercises since 2005 is $388,846.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-12-20||Esposito Pamela (Chief Business Officer)||Option Ex||25,700||1.75||44,975|
|2019-11-26||Kaufman Howard (Chief Medical Officer)||Option Ex||58,067||3.30||191,621|
|2019-11-18||Rhodes Jason P (Director)||Buy||1,100,000||13.61||14,971,000|
|2019-11-06||Love Colin (Chief Operating Officer)||Sale||22,500||17.01||382,725|
|2019-11-06||Coffin Robert (President and CEO)||Sale||48,500||17.01||824,985|
|2019-11-06||Astley-sparke Philip (Executive Chairman)||Sale||29,000||17.01||493,290|
|2019-11-04||Love Colin (Chief Operating Officer)||Sale||22,500||17.03||383,085|
|2019-11-04||Coffin Robert (President and CEO)||Sale||48,500||17.03||825,761|
|2019-11-04||Astley-sparke Philip (Executive Chairman)||Sale||29,000||17.03||493,754|
|2019-10-31||Love Colin (Chief Operating Officer)||Sale||11,250||17.00||191,250|
|2019-10-31||Coffin Robert (President and CEO)||Sale||24,250||17.00||412,250|
|2019-10-31||Astley-sparke Philip (Executive Chairman)||Sale||14,500||17.00||246,500|
|2019-09-23||Love Colin (Chief Operating Officer)||Sale||11,250||17.05||191,812|
|2019-09-23||Coffin Robert (President and CEO)||Sale||24,250||17.05||413,462|
|2019-09-23||Astley-sparke Philip (Executive Chairman)||Sale||14,500||17.05||247,225|
|2018-12-13||Esposito Pamela (Chief Business Officer)||Option Ex||87,000||1.75||152,250|
|2018-07-24||Forbion Capital Fund Iii Cooperatief U.a. (10% Owner)||Buy||133,333||15.00||1,999,995|
|2018-07-24||Slootweg Hugo Alexander (Director)||Buy||133,333||15.00||1,999,995|
|2018-07-24||Paster Anne-mari (10% Owner)||Buy||266,667||15.00||4,000,005|
|2018-07-24||Koppel Adam (Director)||Buy||500,000||15.00||7,500,000|
|2018-07-24||Slattery Joseph P (Director)||Buy||6,667||15.00||100,005|
Insider trading activities including stock purchases, stock sales, and option exercises of REPL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Replimune Group, Inc. (symbol REPL, CIK number 1737953) see the Securities and Exchange Commission (SEC) website.